AU2014201847B2 — Sulfonyl amide derivatives for the treatment of abnormal cell growth
Assigned to Pfizer Products Inc · Expires 2015-12-24 · 10y expired
What this patent protects
Abstract The present invention relates to a compound of the formula I R4 -N HN-(CR2 R3), B 5 (R)m wherein R' to R6, A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This inv…
USPTO Abstract
Abstract The present invention relates to a compound of the formula I R4 -N HN-(CR2 R3), B 5 (R)m wherein R' to R6, A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the 0 treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.